A client having a myocardial infarction is receiving alteplase (Activase) therapy. Which of the following actions should be carried out by the nurse to monitor for the most frequent adverse effect?

Question

Quizplus · Accepted Answer

Alteplase (Activase) is a thrombolytic agent used to dissolve blood clots, such as those found in the coronary arteries during a myocardial infarction. The most frequent adverse effect of thrombolytic therapy is bleeding due to the drug's mechanism of action, which involves breaking down clots and potentially affecting other areas of the body where clotting is necessary to prevent or stop bleeding. Therefore, monitoring for bleeding is essential when a patient is receiving alteplase.

A Client Having a Myocardial Infarction Is Receiving Alteplase (Activase)